VMD

Viemed HealthcareTSX:VMD Stock Report

Market Cap

CA$300.3m

7D

-2.7%

1Y

-32.5%

Updated

22 Sep, 2021

Data

Company Financials +
VMD fundamental analysis
Snowflake Score
Valuation1/6
Future Growth3/6
Past Performance2/6
Financial Health6/6
Dividends0/6

VMD Overview

Viemed Healthcare, Inc., through its subsidiaries, provides in-home durable medical equipment and post-acute respiratory healthcare services to patients in the United States.

Price History & Performance

Summary of all time highs, changes and price drops for Viemed Healthcare
Historical stock prices
Current Share PriceCA$7.55
52 Week HighCA$7.37
52 Week LowCA$13.69
Beta0.63
1 Month Change-7.48%
3 Month Change-16.11%
1 Year Change-32.47%
3 Year Change16.51%
5 Year Changen/a
Change since IPO214.58%

Recent News & Updates

Jun 04
Shareholders May Not Be So Generous With Viemed Healthcare, Inc.'s (TSE:VMD) CEO Compensation And Here's Why

Shareholders May Not Be So Generous With Viemed Healthcare, Inc.'s (TSE:VMD) CEO Compensation And Here's Why

Under the guidance of CEO Casey Hoyt, Viemed Healthcare, Inc. ( TSE:VMD ) has performed reasonably well recently. As...

May 18
Viemed Healthcare (TSE:VMD) Could Easily Take On More Debt

Viemed Healthcare (TSE:VMD) Could Easily Take On More Debt

Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...

Shareholder Returns

VMDCA HealthcareCA Market
7D-2.7%-0.5%-1.6%
1Y-32.5%21.1%32.3%

Return vs Industry: VMD underperformed the Canadian Healthcare industry which returned 18% over the past year.

Return vs Market: VMD underperformed the Canadian Market which returned 28.6% over the past year.

Price Volatility

Is VMD's price volatile compared to industry and market?
VMD volatility
VMD Beta0.63
Industry Beta1.2
Market Beta1

Stable Share Price: VMD is less volatile than 75% of Canadian stocks over the past 3 months, typically moving +/- 4% a week.

Volatility Over Time: VMD's weekly volatility (4%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
2006575Casey Hoythttps://www.viemed.com

Viemed Healthcare, Inc., through its subsidiaries, provides in-home durable medical equipment and post-acute respiratory healthcare services to patients in the United States. The company offers respiratory services and related equipment, including non-invasive ventilators; bi-level, continuous, and automatic continuous positive airway pressure (PAP) machines; and oxygen therapy, as well as services of respiratory therapists; and respiratory disease management, neuromuscular care, and oxygen therapy services. It also provides in-home sleep apnea testing services to determine the existence of sleep apnea at home.

Valuation

Is Viemed Healthcare undervalued compared to its fair value and its price relative to the market?

21.21x

Price to Earnings (PE) ratio


Share Price vs. Fair Value

Below Fair Value: VMD (CA$7.55) is trading above our estimate of fair value (CA$5.01)

Significantly Below Fair Value: VMD is trading above our estimate of fair value.


Price To Earnings Ratio

PE vs Industry: VMD is poor value based on its PE Ratio (21.2x) compared to the Canadian Healthcare industry average (21.1x).

PE vs Market: VMD is poor value based on its PE Ratio (21.2x) compared to the Canadian market (12.5x).


Price to Earnings Growth Ratio

PEG Ratio: VMD is poor value based on its PEG Ratio (1.3x)


Price to Book Ratio

PB vs Industry: VMD is good value based on its PB Ratio (2.7x) compared to the CA Healthcare industry average (3x).


Future Growth

How is Viemed Healthcare forecast to perform in the next 1 to 3 years based on estimates from 5 analysts?

15.8%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: VMD's forecast earnings growth (15.8% per year) is above the savings rate (1.5%).

Earnings vs Market: VMD's earnings (15.8% per year) are forecast to grow faster than the Canadian market (12% per year).

High Growth Earnings: VMD's earnings are forecast to grow, but not significantly.

Revenue vs Market: VMD's revenue (14.1% per year) is forecast to grow faster than the Canadian market (6.1% per year).

High Growth Revenue: VMD's revenue (14.1% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if VMD's Return on Equity is forecast to be high in 3 years time


Past Performance

How has Viemed Healthcare performed over the past 5 years?

37.7%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: VMD has high quality earnings.

Growing Profit Margin: VMD's current net profit margins (9.2%) are lower than last year (26.6%).


Past Earnings Growth Analysis

Earnings Trend: VMD's earnings have grown significantly by 37.7% per year over the past 5 years.

Accelerating Growth: VMD's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: VMD had negative earnings growth (-61.5%) over the past year, making it difficult to compare to the Healthcare industry average (56.6%).


Return on Equity

High ROE: VMD's Return on Equity (12.9%) is considered low.


Financial Health

How is Viemed Healthcare's financial position?


Financial Position Analysis

Short Term Liabilities: VMD's short term assets ($47.0M) exceed its short term liabilities ($18.3M).

Long Term Liabilities: VMD's short term assets ($47.0M) exceed its long term liabilities ($6.4M).


Debt to Equity History and Analysis

Debt Level: VMD's debt to equity ratio (8.1%) is considered satisfactory.

Reducing Debt: VMD's debt to equity ratio has reduced from 9.6% to 8.1% over the past 5 years.

Debt Coverage: VMD's debt is well covered by operating cash flow (312.2%).

Interest Coverage: VMD's interest payments on its debt are well covered by EBIT (35.3x coverage).


Balance Sheet


Dividend

What is Viemed Healthcare current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

Notable Dividend: Unable to evaluate VMD's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate VMD's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if VMD's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if VMD's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of VMD's dividend in 3 years as they are not forecast to pay a notable one for the Canadian market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

3.5yrs

Average management tenure


CEO

Casey Hoyt (44 yo)

3.75yrs

Tenure

US$2,219,902

Compensation

Mr. Casey Hoyt has been Director of Viemed Healthcare, Inc. since December 14, 2016 and Chief Executive Officer since December 2017. Mr. Hoyt served as Chief Executive Officer of Patient Home Monitoring Co...


CEO Compensation Analysis

Compensation vs Market: Casey's total compensation ($USD2.22M) is above average for companies of similar size in the Canadian market ($USD510.52K).

Compensation vs Earnings: Casey's compensation has been consistent with company performance over the past year.


Leadership Team

Experienced Management: VMD's management team is considered experienced (3.5 years average tenure).


Board Members

Experienced Board: VMD's board of directors are considered experienced (3.8 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

Viemed Healthcare, Inc.'s employee growth, exchange listings and data sources


Key Information

  • Name: Viemed Healthcare, Inc.
  • Ticker: VMD
  • Exchange: TSX
  • Founded: 2006
  • Industry: Health Care Services
  • Sector: Healthcare
  • Market Cap: CA$300.262m
  • Shares outstanding: 39.77m
  • Website: https://www.viemed.com

Number of Employees


Location

  • Viemed Healthcare, Inc.
  • 625 East Kaliste Saloom Road
  • Lafayette
  • Louisiana
  • 70508
  • United States

Listings


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2021/09/22 22:45
End of Day Share Price2021/09/22 00:00
Earnings2021/06/30
Annual Earnings2020/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.